Artiva Biotherapeutics’ (NASDAQ:ARTV – Get Free Report) lock-up period is set to expire on Wednesday, January 15th. Artiva Biotherapeutics had issued 13,920,000 shares in its IPO on July 19th.

This fun logo quiz features five challenging rounds, and includes themed rounds on car logos, food companies and fashion brands. If there’s one thing lockdown taught us, it was that quizzes were a ...

Barclays PLC purchased a new position in shares of Artiva Biotherapeutics, Inc. (NASDAQ:ARTV – Free Report) in the 3rd quarter, according to the company in its most recent Form 13F filing with ...

GCC-4001 is under clinical development by Artiva Biotherapeutics and currently in Phase I for Rheumatoid Arthritis. According to GlobalData, Phase I drugs for Rheumatoid Arthritis have a 69% phase ...

THRD Third Harmonic Bio, Inc.

The NHL has some of the most historic and unique logos in the entire world of sports. With the Seattle Kraken now in the fold, we can rank 32 logos around the league. There are many great logos ...

This post will discuss the top 10 famous logo designers and their iconic work. From Paul Rand's IBM logo to Michael Bierut's Mastercard. Logos are one of the most vital parts of a brand's identity. A ...

The Chief Electoral Officer, Delhi, is conducting a Special Summary Revision of electoral rolls with the qualifying date set as January 1, 2025, a statement said on Tuesday, highlighting the CEO's ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Artiva Biotherapeutics, Inc. (NASDAQ:ARTV) is a clinical-stage biotechnology company that has captured the attention of investors and analysts alike with its innovative approach to developing natural ...